A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity
about
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysisInduction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2)Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.The role of genetic polymorphisms in environmental health.Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotectorAssociation between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studiesVariation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.Benzene, NQO1, and genetic susceptibility to cancer.Relationships between metabolic and non-metabolic susceptibility factors in benzene toxicity.Recent developments in the understanding of benzene toxicity and leukemogenesis.NQO1 stabilizes p53 through a distinct pathway.NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion.A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.Genetic predisposition and treatment-related leukemia.NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis.Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.Genetic susceptibility to benzene toxicity in humans.Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation.Generation of stable ARE- driven reporter system for monitoring oxidative stress.Xenobiotic metabolism and the mechanism(s) of benzene toxicity.Quinone reductases multitasking in the metabolic world.NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North ChinaAssociation of NQO1 polymorphism with spontaneous breast cancer in two independent populations.Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.Detection of quinone oxidoreductase 1 (NQO1) single-nucleotide polymorphisms (SNP) related to benzene metabolism in immortalized B lymphocytes from a Chinese Han population.Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells.E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.Comparative distribution of Lysyl Oxidase (G473A) and NQO1 (C609T) polymorphism among tea-garden workers (habitual chewers of betel quid) of Darjeeling district and Kolkata city of West Bengal.Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure.Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.Shanghai Health Study (2001-2009): What was learned about benzene health effects?[Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma].Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL.Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes.Benzoate and Sorbate Salts: A Systematic Review of the Potential Hazards of These Invaluable Preservatives and the Expanding Spectrum of Clinical Uses for Sodium Benzoate
P2860
Q21203666-FD5BD79B-7EE0-40B9-B662-3DFD45A52FFDQ23919661-595531A8-95D1-4580-92BB-145760EC5437Q24811463-2C4E525E-3B93-44C1-98B4-40D49517FDCBQ24815139-DDD74CED-81C1-48A3-B2D9-40BDCCA60990Q28217043-B1886532-F8FA-4E70-96EA-81FFECA94F2DQ28278566-3118E277-2551-4864-8D06-DFB12C8ABC8AQ28307135-76CDF3A2-B6D7-4E63-8F43-5891307AB7B4Q30498669-0A536B0B-A4E8-4D14-ACE2-BF04F7850F77Q33679449-93997520-F5D0-4182-803C-5AE26D42CB12Q33756205-A5C1F11A-CC63-4163-BA8A-6FB432ECF7ABQ33859426-0AAD5D07-76EC-4141-B4A9-CE160F6FA9CEQ34016489-190B793F-079C-4AC1-985F-BDE73B0A1232Q34028119-346D40C7-B323-4F3C-87A6-C8CFC72CE512Q34137818-3E0E77C1-B1ED-4B13-998C-CC8A5E80FA61Q34243517-9234564B-5FF4-4733-A2A4-48404454A4A8Q34554415-1ED758D3-5670-4567-B79A-04415FD00013Q34623580-D0CBDFC4-4853-4CEC-87D9-82F3951581EEQ34663997-12010354-61BA-4B7A-A83F-C50CCD9CBFEAQ34708876-CBB0728A-6842-4559-9250-740E965CB597Q34846124-BBD79A9D-0AE2-4684-AB4A-E6D3556A934DQ35401796-F469CACD-B3BD-43EC-8D1C-A6C8634D3188Q35906485-E43BEFEF-09B2-439D-B8D3-B1B01BE6F3B6Q35956153-A4B0A8E4-B5EB-4726-8998-F81E06DA3DCAQ35956182-B9506305-C5DA-40BB-9C40-38E7129AFBD6Q36190589-C73357C7-60CB-4858-AA79-B0299FCAD901Q36697159-376B2572-3BD9-4540-BFAB-519A4D80E91AQ36835902-7C6E32FF-585F-4365-9B08-AA4BB5FD7B6CQ37698404-DAE19FCB-2CE6-4E87-B3C3-5E975E662BD0Q39714999-07ABCBE6-399B-4D9D-9838-71ED41C6FF43Q39838122-26D02D46-130A-4566-A9B3-CAFDE91A2AF6Q41817177-F5E135E3-F5A1-47F9-867B-7F82F702BF41Q41855622-750536A1-2685-440E-9270-28DE2E413FB4Q43839159-0663F696-EAA7-4E82-B3D0-56132B84934AQ43844086-464784A0-F65B-4631-9DBA-33C57A9A96F1Q44156025-0BE8D232-4567-425E-A989-07947C91299AQ47178986-849B08E9-22DB-44E8-BDC0-559C06D7656FQ53379524-273B95E9-0049-48F4-8152-CA68601351ABQ53851433-7854D8CE-418F-43D7-8AE6-DF96F7B5BC2EQ54344319-43FFDD61-B9F4-464D-84D6-6DAA97667D42Q56481952-6BA587EB-D0AA-4703-AFC8-CF065047960E
P2860
A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@ast
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en-gb
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@nl
type
label
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@ast
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en-gb
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@nl
prefLabel
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@ast
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en-gb
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@nl
P2093
P2860
P356
P1476
A potential mechanism underlyi ...... e 1 (NQO1) to benzene toxicity
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.14.8150
P407
P577
1999-07-06T00:00:00Z